Oxidative Degradation Products Of Atorvastatin Calcium

Patent No. EP1771455 (titled "Oxidative Degradation Products Of Atorvastatin Calcium") was filed by LEK Pharmaceuticals DD on Jul 15, 2005. The application was issued on May 11, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1771455

LEK PHARMACEUTICALS DD
Application Number
EP05760907A
Filing Date
Jul 15, 2005
Status
Revoked
Aug 17, 2018
Publication Date
May 11, 2016